Diagnosis of alpha 1 antitrypsin deficiency in primary care

Miriam Barrecheguren Fernandez (Barcelona, Spain), Miriam Barrecheguren, Mónica Monteagudo, Carles Llor, Eulalia Borrell, Cristina Esquinas, Jaume Ferrer, Marc Miravitlles

Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Session: Management of COPD and other respiratory diseases in primary care
Session type: Thematic Poster Session
Number: 3866
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Miriam Barrecheguren Fernandez (Barcelona, Spain), Miriam Barrecheguren, Mónica Monteagudo, Carles Llor, Eulalia Borrell, Cristina Esquinas, Jaume Ferrer, Marc Miravitlles. Diagnosis of alpha 1 antitrypsin deficiency in primary care. Eur Respir J 2015; 46: Suppl. 59, 3866

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015


The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Screening for alpha1-antitrypsin deficiency at a university hospital
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

The disease burden of mild asthmatics in China
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Lung transplantation in alpha 1 antitrypsin deficiency
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014


Causes of death in COPD patients in primary care setting - 6 years follow-up
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Prevalence of asthma symptoms, diagnosis and treatment use in Romania
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Clinical features of alpha one antitrypsin deficiency in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015